China's CSPC Pharmaceutical rises on robust H1 earnings forecast

CSPC PHARMACEUTICAL

28/07/2026 04:18

** Shares of CSPC Pharmaceutical Group 1093.HK rise 4.2% to HK$8.65, on course for their biggest one-day pct gain since July 20
** The Chinese drug manufacturer expects its H1 net profit to jump 131.4%-143.1% y/y to 5.9 bln yuan-6.2 bln yuan ($871.79 mln-$916.12 mln) 
** Says the growth is due to significant increase in licence fee income and stable growth in sales revenue from finished drugs business 
** YTD, stock down 1.3%, Hang Seng Biotech Index .HSBIO down 2.1%




($1 = 6.7677 Chinese yuan renminbi)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))